Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2985 - 2992 of 12016 results
TCPA Regulatory Update — STIR/SHAKEN and Robocall Mitigation Database Implementation Take Effect
July 15, 2021| Article| Viewpoint
TCPA Regulatory Update — Strong Support for USTelecom to Remain Leader of Registered Traceback Consortium
July 15, 2021| Article| Viewpoint
TCPA Regulatory Update — FCC Adopts Rules for Private Entity Robocall Reporting and Releases Second Call Blocking Report
July 15, 2021| Article| Viewpoint
TCPA Litigation Update — Defending TCPA Cases in the Aftermath of the Supreme Court’s Ruling in TransUnion LLC v. Ramirez
July 15, 2021| Article| Viewpoint
UPDATE: NYC Dept of Consumer Affairs Publishes Sample Biometric Signage
July 15, 2021| Blog| Viewpoint
Energy-as-a-Service: the Netflix-ification of the Energy Market?
July 15, 2021| Blog| Viewpoint
Integrity Through Compliance: Dionne Lomax and Joe Miller Take a Deep Dive Into Consent Decree Enforcement at FTC and DOJ
July 14, 2021| Podcast| Viewpoint
Climate Disclosures?!
July 14, 2021| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|